古汉医药(000590.SZ)：预计2025年净亏损4500万元—5500万元

Group 1 - The core viewpoint of the article is that Guohan Pharmaceutical (000590.SZ) has announced a forecast for its 2025 annual performance, indicating a projected net loss for the period [1] - The company expects a net loss attributable to shareholders of between 45 million and 55 million yuan, compared to a loss of 125 million yuan in the same period last year [1] - The forecasted net loss after excluding non-recurring gains and losses is expected to be between 55 million and 65 million yuan, compared to a loss of 170 million yuan in the previous year [1]